Literature DB >> 33915506

A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders.

Hannah C Levy1, Emily M O'Bryan2, David F Tolin3.   

Abstract

Cognitive-behavioral therapy (CBT) is a first-line treatment for anxiety and related disorders, with large pre- to post-treatment effect sizes. Rates of relapse, or the likelihood that a state of remission will be maintained once treatment is withdrawn, have been relatively neglected in CBT outcome studies. The present meta-analysis aimed to determine the overall rate of relapse in CBT for anxiety and related disorders. A secondary aim was to assess whether demographic, clinical, and methodological factors were associated with rates of relapse in CBT. Articles were identified from prior CBT meta-analyses and review papers and from literature searches using the PsycINFO and Medline electronic databases, with 17 full-length articles retained for meta-analysis (total N = 337 patients). Results showed an overall relapse rate of 14 %, which did not significantly differ between diagnoses. The way in which relapse was defined was significantly associated with relapse rates; when relapse was defined as meeting diagnostic criteria, estimates were lower than when alternative definitions were used. The findings indicate that relapse following symptom remission occurs in a minority of patients, suggesting that future treatment development and refinement efforts should focus on improving relapse prevention skills and interventions to minimize risk of relapse.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; CBT; Relapse; Remission

Year:  2021        PMID: 33915506     DOI: 10.1016/j.janxdis.2021.102407

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  5 in total

1.  Metacognitive therapy and work-focused interventions for patients on sick leave due to anxiety and depression: study protocol for a randomised controlled wait-list trial.

Authors:  Kenneth Sandin; Ragne G H Gjengedal; Kåre Osnes; Marit Hannisdal; Torkil Berge; Jonas S R Leversen; Lars G Røv; Silje Endresen Reme; Suzanne Lagerveld; Roland Blonk; Hans M Nordahl; Gemma Shields; Adrian Wells; Odin Hjemdal
Journal:  Trials       Date:  2021-11-27       Impact factor: 2.279

2.  A pragmatic randomized controlled trial of a group self-management support program versus treatment-as-usual for anxiety disorders: study protocol.

Authors:  Pasquale Roberge; Janie Houle; Jean-Rémy Provost; Simon Coulombe; Annie Beaudin; Peter Bower; Félix Camirand Lemyre; Martin Drapeau; Marc-Simon Drouin; Catherine Hudon; Martin D Provencher; Helen-Maria Vasiliadis
Journal:  BMC Psychiatry       Date:  2022-02-21       Impact factor: 3.630

3.  Mental Health in Australia: Psychological Distress Reported in Six Consecutive Cross-Sectional National Surveys From 2001 to 2018.

Authors:  Joanne Enticott; Shrinkhala Dawadi; Frances Shawyer; Brett Inder; Ellie Fossey; Helena Teede; Sebastian Rosenberg; Ingrid Ozols Am; Graham Meadows
Journal:  Front Psychiatry       Date:  2022-04-01       Impact factor: 5.435

4.  Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis.

Authors:  Esther Krijnen-de Bruin; Willemijn Scholten; Anna Muntingh; Otto Maarsingh; Berno van Meijel; Annemieke van Straten; Neeltje Batelaan
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

5.  The effectiveness of schema therapy for patients with anxiety disorders, OCD, or PTSD: A systematic review and research agenda.

Authors:  Nancy Peeters; Boris van Passel; Julie Krans
Journal:  Br J Clin Psychol       Date:  2021-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.